Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients

You may be eligible if

• You have a confirmed diagnosis of non-squamous, non-endocrine non-small cell lung cancer.
• Your cancer biopsy has sufficient cancer cells to be tested for the (Epidermal Growth Factor Receptor (EGFR) mutation, the ALK fusion gene abnormality and the research ALK testing.
• Your lung cancer biopsy is determined not to have a mutation in the EGFR gene.
• You are 19 years old or older.
• You fully understand the study and give informed consent to participate as demonstrated by signing the consent.